The mutual control of iron and erythropoiesis
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Summary: Background: Iron is essential for hemoglobin synthesis during terminal erythropoiesis. To supply adequate iron the carrier transferrin is required together with transferrin receptor endosomal cycle and normal mitochondrial iron utilization. Iron and iron protein deficiencies result in different types of anemia. Iron‐deficiency anemia is the commonest anemia worldwide due to increased requirements, malnutrition, chronic blood losses and malabsorption. Mutations of transferrin, transferrin receptor cycle proteins, enzymes of the first step of heme synthesis and iron sulfur cluster biogenesis lead to rare anemias, usually accompanied by iron overload. Hepcidin plays an indirect role in erythropoiesis by controlling plasma iron. Inappropriately high hepcidin levels characterize the rare genetic iron‐refractory iron‐deficiency anemia (IRIDA) and the common anemia of chronic disease. Iron modulates both effective and ineffective erythropoiesis: iron restriction reduces heme and alpha‐globin synthesis that may be of benefit in thalassemia. Material and Methods: This review relies on the analysis of the most recent literature and personal data. Results: Erythropoiesis controls iron homeostasis, by releasing erythroferrone that inhibits hepcidin transcription to increase iron acquisition in iron deficiency, hypoxia and EPO treatment. Erythroferrone, produced by EPO‐stimulated erythropoiesis, inhibits hepcidin only when the activity of BMP/SMAD pathway is low, suggesting that EPO somehow modulates the latter signaling. Erythroblasts sense circulating iron through the second transferrin receptor (TFR2) that, in animal models, modulates the sensitivity of the erythroid cells to EPO. Discussion: The advanced knowledge of the regulation of systemic iron homeostasis and erythropoiesis‐mediated hepcidin regulation is leading to the development of targeted therapies for anemias and iron disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120 · cited 1×
“present in RNA UTR of several genes [1].”
BackgroundSelf-citationCamaschella, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1401038 · Cited by 1,678
Self-citationIdentification of erythroferrone as an erythroid regulator of iron metabolism
Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014) · Nature Genetics · doi:10.1038/ng.2996 · Cited by 1,127 · cited 13×
“ERFE is a member of the C1q-tumor-necrosis factor (TNF)-alpha family, produced by several tissues, but increased by EPO injection only in maturing erythroblasts.”
BackgroundInfluentialHigh levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854 · cited 1×
“In addition, it was found in extremely high concentrations in the sera of beta-thalassemia patients [26], although this”
BackgroundThe gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
Camaschella, C., Roetto, A., Calì, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., & Gasparini, P. (2000) · Nature Genetics · doi:10.1038/75534 · Cited by 803
Self-citationMutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
Finberg, K. E., Heeney, M. M., Campagna, D. R., Aydınok, Y., Pearson, H. A., Hartman, K. R., Mayo, M. M., Samuel, S. M., Strouse, J. J., Markianos, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.130 · Cited by 675
Transferrin receptor is necessary for development of erythrocytes and the nervous system
Levy, J. E., Jin, O., Fujiwara, Y., Kuo, F., & Andrews, N. (1999) · Nature Genetics · doi:10.1038/7727 · Cited by 574
Silvestri, L., Pagani, A., Nai, A., De Domenico, I., Kaplan, J., & Camaschella, C. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.012 · Cited by 555 · cited 1×
“Iron-refractory iron deficiency anemia [15] is a rare recessive disorder due to mutations of TMPRSS6/matriptase-2, the hepatocyte serine protease, which inhibits hepcidin by cleaving the BMP co-receptor hemojuvelin from plasma membrane [16].”
BackgroundSelf-citationMancias, J. D., Pontano Vaites, L., Nissim, S., Biancur, D. E., Kim, A. J., Wang, X., Liu, Y., Goessling, W., Kimmelman, A. C., & Harper, J. W. (2015) · eLife · doi:10.7554/elife.10308 · Cited by 552
Oudit, G. Y., Sun, H., Trivieri, M. G., Koch, S. E., Dawood, F., Ackerley, C., Yazdanpanah, M., Wilson, G. J., Schwartz, A., Liu, P. P., et al. (2003) · Nature Medicine · doi:10.1038/nm920 · Cited by 480
Suppression of hepcidin during anemia requires erythropoietic activity
Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., & Rivera, S. (2006) · Blood · doi:10.1182/blood-2006-06-028787 · Cited by 472 · cited 1×
“It has been shown that EPO by itself cannot inhibit hepcidin production when erythropoiesis is suppressed by cytotoxic drugs [23].”
BackgroundMyonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis
Seldin, M. M., Peterson, J. M., Byerly, M. S., Wei, Z., & Wong, G. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.336834 · Cited by 406
Liver iron concentrations and urinary hepcidin in -thalassemia
Origa, R., Galanello, R., Ganz, T., Giagu, N., Maccioni, L., Faa, G., & Nemeth, E. (2007) · Haematologica · doi:10.3324/haematol.10842 · Cited by 365 · cited 1×
“Pathologic low hepcidin levels are found in inherited anemias with high degree of ineffective erythropoiesis, the so-called iron-loading anemias, nontransfusion-dependent beta-thalassemia being a paradigmatic example [24].”
BackgroundFurin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
Silvestri, L., Pagani, A., & Camaschella, C. (2008) · Blood · doi:10.1182/blood-2007-07-100677 · Cited by 311
Self-citationKautz, L., Jung, G., Du, X., Gabayan, V., Chapman, J., Nasoff, M., Nemeth, E., & Ganz, T. (2015) · Blood · doi:10.1182/blood-2015-07-658419 · Cited by 306 · cited 1×
“ERFE contributes to iron loading in beta-thalassemia mice [31].”
BackgroundJenkitkasemwong, S., Wang, C.-Y., Coffey, R., Zhang, W., Chan, A., Biel, T., Kim, J.-S., Hojyo, S., Fukada, T., & Knutson, M. D. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.002 · Cited by 245
Guernsey, D. L., Jiang, H., Campagna, D. R., Evans, S. C., Ferguson, M., Kellogg, M. D., Lachance, M., Matsuoka, M., Nightingale, M., Rideout, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.359 · Cited by 244 · cited 3×
“The X-linked form is due to delta-aminolevulinic acid synthase 2 deficiency, while the recessive form is due to mutations of the mitochondrial glycine importer SLC25A38 [18].”
Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis
Ramos, E., Ruchala, P., Goodnough, J. B., Kautz, L., Preza, G. C., Nemeth, E., & Ganz, T. (2012) · Blood · doi:10.1182/blood-2012-07-440743 · Cited by 213 · cited 1×
“the development of compounds against molecular targets shown to be efficacious in preclinical studies, as anti-TMPRSS6 short interference RNA [43] or allele-specific oligonucleotides [44] or mini hepcidin modified for oral treatment [45] to increase hepcidin”
BackgroundThe IRP1-HIF-2α Axis Coordinates Iron and Oxygen Sensing with Erythropoiesis and Iron Absorption
Anderson, S. A., Nizzi, C. P., Chang, Y.-I., Deck, K. M., Schmidt, P. J., Galy, B., Damnernsawad, A., Broman, A. T., Kendziorski, C., Hentze, M. W., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.007 · Cited by 211 · cited 2×
“Erythropoietin (EPO) is produced by the kidney under the stimulus of hypoxia but is also influenced in part by body iron (dashed line) [14].”
BackgroundSchmidt, P. J., Toudjarska, I., Sendamarai, A. K., Racie, T., Milstein, S., Bettencourt, B. R., Hettinger, J., Bumcrot, D., & Fleming, M. D. (2013) · Blood · doi:10.1182/blood-2012-09-453977 · Cited by 204
Ineffective erythropoiesis and regulation of iron status in iron loading anaemias
Camaschella, C., & Nai, A. (2016) · British Journal of Haematology · doi:10.1111/bjh.13820 · Cited by 172
Self-citationThe second transferrin receptor regulates red blood cell production in mice
Nai, A., Lidonnici, M. R., Rausa, M., Mandelli, G., Pagani, A., Silvestri, L., Ferrari, G., & Camaschella, C. (2015) · Blood · doi:10.1182/blood-2014-08-596254 · Cited by 156 · cited 2×
“Erfe production, mimicking events that occur in mild iron deficiency [38].”
BackgroundSelf-citationErythroferrone contributes to recovery from anemia of inflammation
Kautz, L., Jung, G., Nemeth, E., & Ganz, T. (2014) · Blood · doi:10.1182/blood-2014-06-584607 · Cited by 152
Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB
Sonnweber, T., Nachbaur, D., Schroll, A., Nairz, M., Seifert, M., Demetz, E., Haschka, D., Mitterstiller, A.-M., Kleinsasser, A., Burtscher, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305317 · Cited by 145
Nai, A., Rubio, A., Campanella, A., Gourbeyre, O., Artuso, I., Bordini, J., Gineste, A., Latour, C., Besson-Fournier, C., Lin, H. Y., et al. (2016) · Blood · doi:10.1182/blood-2015-11-681494 · Cited by 97 · cited 3×
“How the effect of ERFE is co-ordinated with the suppression of BMP pathway is unknown [32].”
BackgroundSelf-citationTransferrin is a major determinant of hepcidin expression in hypotransferrinemic mice
Bartnikas, T. B., Andrews, N. C., & Fleming, M. D. (2011) · Blood · doi:10.1182/blood-2010-05-287359 · Cited by 77 · cited 1×
“Manipulation of atransferrinemic mice has highlighted a role for transferrin in hepcidin regulation independently from erythropoiesis [6].”
BackgroundHow I manage patients with atypical microcytic anaemia
Camaschella, C. (2013) · British Journal of Haematology · doi:10.1111/bjh.12081 · Cited by 49
Self-citation
Research works printed but not linked: 18
- 10.1016/j.celrep.2015.09.023 · DOI · Paper page
- 10.1016/j.ebiom.2015.09.041 · DOI · Paper page
- 10.1073/pnas.1511701112 · DOI
- 10.1182/blood-2005-06-2477 · DOI · Paper page
- 10.1182/blood-2011-01-329011 · DOI
- 10.3324/haematol.2012.075515 · DOI · Paper page
- 10.1016/j.bbamcr.2014.09.009 · DOI · Paper page
- 10.1172/JCI40372 · DOI · Paper page
- 10.1111/j.1365-2141.2008.07290.x · DOI
- 10.1016/j.exphem.2015.03.001 · DOI
- 10.3324/haematol.2012.069807 · DOI · Paper page
- 10.1016/j.bcmd.2007.06.023 · DOI
- 10.1182/blood-2010-04-281360 · DOI · Paper page
- 10.1182/blood-2004-06-2477 · DOI · Paper page
- 10.3324/haematol.2014.118521 · DOI · Paper page
- 10.1074/jbc.M114.632778 · DOI
- 10.1074/jbc.M114.611913 · DOI · Paper page
- 10.1172/JCI66969 · DOI · Paper page
Cited by
Iron metabolism and iron disorders revisited in the hepcidin era
Camaschella, C., Nai, A., & Silvestri, L. (2020) · Haematologica · doi:10.3324/haematol.2019.232124 · Cited by 734
“When plasma iron concentration is high, diferric transferrin binds TFR2 inducing upregulation of hepcidin in hepatocytes and a reduction of erythropoietin responsiveness in erythroid cells 9 where TFR2 binds erythropoietin receptors.”
Self-citationOriga, R. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.173 · Cited by 509
On Iron Metabolism and Its Regulation
Vogt, A.-C. S., Arsiwala, T., Mohsen, M., Vogel, M., Manolova, V., & Bachmann, M. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094591 · Cited by 456
Means, R. T. (2020) · Nutrients · doi:10.3390/nu12020447 · Cited by 349
The transferrin receptor: the cellular iron gate
Gammella, E., Buratti, P., Cairo, G., & Recalcati, S. (2017) · Metallomics · doi:10.1039/c7mt00143f · Cited by 311
Metadata
- Authors
- Camaschella, C., Pagani, A., Nai, A., & Silvestri, L.
- Venue
- International Journal of Laboratory Hematology
- Publisher
- Wiley
- Published
- 2016-05
- Volume
- 38
- Issue
- S1
- Pages
- 20-26
- ISSN
- 1751-5521 (ISSN-L)
- 1751-553X
- OpenAlex
- W2358356329
- Cited by
- 97
- References
- 27
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor, 8 d)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Funders
- Italian Ministry of Health, Ricerca Finalizzata (RF 20102312048)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.